Bridgeway Capital Management’s Quest Diagnostics DGX Stock Holding History

Bridgeway Capital Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-28,300	Closed	-$4.43M	–	1391
2022 Q4	$4.43M	Sell	28,300 -36,200	-56%	-$5.2M	0.11%	303
2022 Q3	$7.91M	Sell	64,500 -25,500	-28%	-$3.36M	0.21%	131
2022 Q2	$12M	Hold	90,000	–	–	0.27%	83
2022 Q1	$12.3M	Sell	90,000 -7,350	-8%	-$1.02M	0.24%	129
2021 Q4	$16.8M	Buy	97,350 +21,000	+28%	+$3.2M	0.31%	60
2021 Q3	$11.1M	Buy	+76,350	New	+$11.2M	0.21%	133
2017 Q2	–	Sell	-628,000	Closed	-$61.7M	–	1430
2017 Q1	$61.7M	Buy	628,000 +24,400	+4%	+$2.33M	0.75%	25
2016 Q4	$55.5M	Buy	603,600 +7,800	+1%	+$672K	0.72%	23
2016 Q3	$50.4M	Hold	595,800	–	–	0.75%	12
2016 Q2	$48.5M	Buy	+595,800	New	+$45.4M	0.75%	12
2016 Q1	–	Sell	-257,100	Closed	-$18.3M	–	1442
2015 Q4	$18.3M	Hold	257,100	–	–	0.34%	95
2015 Q3	$15.8M	Hold	257,100	–	–	0.33%	101
2015 Q2	$18.6M	Hold	257,100	–	–	0.37%	78
2015 Q1	$19.8M	Buy	257,100 +100,300	+64%	+$7.18M	0.41%	56
2014 Q4	$10.5M	Hold	156,800	–	–	0.24%	102
2014 Q3	$9.52M	Buy	156,800 +34,700	+28%	+$2.14M	0.24%	83
2014 Q2	$7.17M	Buy	+122,100	New	+$7.15M	0.19%	113

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bridgeway Capital Management's DGX Position: Q1 2023 in Review

Bridgeway Capital Management sold out of Quest Diagnostics (DGX) in Q1 2023, closing a stake of 28,300 shares — an estimated $4.43M sold.

Bridgeway Capital Management first reported a position in DGX in Q2 2014 and held it in 17 quarters. The position peaked at $61.7M in Q1 2017. 834 funds tracked by Wall St. Rank hold DGX as of Q1 2023.

Bridgeway Capital Management reported no remaining Quest Diagnostics position as of Q1 2023 after selling out during the quarter.
Bridgeway Capital Management sold 28,300 Quest Diagnostics shares in Q1 2023, an estimated $4.43M.
Bridgeway Capital Management first reported a position in Quest Diagnostics in Q2 2014 and held it in 17 quarters.
Bridgeway Capital Management's Quest Diagnostics position peaked at $61.7M in Q1 2017.
834 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2023.

Based on Bridgeway Capital Management's 13F filing for Q1 2023, filed 15 May 2023.